Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations

The majority of invasive mold infections diagnosed in immunocompromised cancer patients include invasive aspergillosis (IA) and mucormycosis. Despite timely and effective therapy, mortality remains considerable. Antifungal agents currently available for the management of these serious infections inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Natesan, Suganthini Krishnan, Chandrasekar, Pranatharthi H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153275/
https://www.ncbi.nlm.nih.gov/pubmed/27994475
http://dx.doi.org/10.2147/IDR.S102207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153275/
https://www.ncbi.nlm.nih.gov/pubmed/27994475
http://dx.doi.org/10.2147/IDR.S102207

Ejemplares similares